The Business Standard's Smart Investor (SI) reports focus on in-depth analysis and timely news concerning strategic investment trends, business deals, and financial manoeuvres within the corporate world.
The Business Standard's Smart Investor (SI) reports focus on in-depth analysis and timely news concerning strategic investment trends, business deals, and financial manoeuvres within the corporate world.
Q1 EBITDA margin contracted by 370bp yoy to 2.9% primarily due to increase in employee cost and other expenses.
The company has posted net profit Rs 5 crore in June 2013 quarter against the loss of Rs 39 crore in year ago quarter.
Markets trimmed early gains and were trading flat as weak Asian cues weighed on investor sentiment.
The transaction is in line with the DLF's ongoing strategy to divest non-core assets, DLF said in a statement.
Markets are expected to open firm but further gains may be capped on weak Asian shares.
Holcim has announced that it will increase its stake in Ambuja Cements from 50.5% to 61.4% in a two stage deal.
EBITDA or operating margin for the quarter expanded to 29.9% in Q1 FY2014 from 27.7% in Q1 FY13.
ITC stock had outperformed the market, rallied 20% in past one month as compared to 8% rise in benchmark Sensex till yesterday.
The Sensex and Nifty have touched an intra-day low of 19,858 mark and 5,925 levels, respectively.
Q1 profit down 21% yoy at Rs 194 crore against Rs 246 crore in year ago quarter.
ITC and Hindustan Unilever down 4% along with heavyweights Wipro,Tata Steel and L&T drag
Analysts expect the IT major to report a flat revenue growth in the recently concluded quarter.
Unilever said that growth is slowing in emerging markets, as macro-economic headwinds influence consumer behavior.
Foreign institutional investors sold Rs 4.04 billion worth of local shares on Wednesday, exchange data shows.
Deutsche Bank downgraded the stock to sell from hold citing higher-than-expected debt and reduced the price target to Rs 42.
Markets extended losses in late morning trades weighed down by profit taking in FMCG majors after recent gains
The company said, the expanded scope of drug price control is likely to have a significant impact on both revenue and profitability.
Gross and Net NPA levels jumped up sequentially by 24.9% and 30.9%, respectively.
Q1 operating margins improved by 100 bps at 14.8% on sequential basis due to decline in other expenditure.
Markets opened lower on Thursday, amid weak global cues, with bank shares extending losses after fresh restrictions by the RBI